Baltimore Washington Eye Center, Maryland

Monday, December 8, 2014

BOTOX® & Type 2 Diabetes

What do BOTOX® and Type 2 Diabetes have to do with each other you ask?  A new study reports that it appears a better understanding of the proteins affected by injections of the wrinkle relaxer BOTOX® could help scientists develop new ways to treat Type 2 Diabetes. BOTOX® Cosmetic is best known as an injection for helping patients smooth fine lines and wrinkles in order to look their best. BOTOX® is also used as treatment for a number of medical conditions including migraine, urinary incontinence, profuse sweating and crossed eyes, among others. In each of these cases, BOTOX® works because it has a paralyzing effect: That is, it relaxes specific muscles, which then provides the desired effect. BOTOX® accomplishes this effect by blocking certain proteins called SNARE (Soluble NSF Attachment Protein Receptor) proteins. It turns out that SNARE proteins in the beta cells of the pancreas help the pancreas secrete insulin; thus, blocking these proteins in the pancreas could lead to insulin resistance which is the hallmark of Type 2 Diabetes. Understanding this mechanism will hopefully provide researchers with new ways to diagnose and treat Type 2 Diabetes in the future.

If you or someone you know has diabetes or even elevated blood sugar levels they should work to prevent diabetic eye disease and problems with regular eye exams by calling Baltimore Washington Eye Center at 800-495-3937, visiting Baltimore Washington Eye Center or facebook.com/baltimorewashingtoneyecenter.

BaltimoreWashington Eye Center is a leading eye care practice with office locations at 200 Hospital Drive, Suite 600, Glen Burnie, Maryland 21061 and River Hill Professional Center, 6100 Day Long Lane, Suite 207, Clarksville, Maryland 21029, serving the greater Baltimore and Washington, D.C. area.